These options offer 99% effectiveness rates and require no daily timing coordination with your weight loss medication
(2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration
Holman RR, Bethel MA, Chan JC, Chiasson JL, Doran Z, Ge J, Gerstein H, Huo Y, McMurray JJ, Ryden L, Liyanage W, Schrder S, Tendera M, Theodorakis MJ, Tuomilehto J, Yang W, Hu D, Pan C, ACE Study Group
Cell Metab 2017;25:1045-1053
We used the registration in closest proximity to study inclusion within an allowed range of one year
ACHIEVE-5 (NCT06109311) A placebo-controlled trial in type 2 diabetes, complementing the active comparator studies by providing clean placebo-adjusted efficacy estimates